Anidulafungin to replace caspofungin in the treatment of fungal infections in cancer patients.
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2015
At a glance
- Drugs Anidulafungin (Primary)
- Indications Candidaemia; Candidiasis; Systemic mycoses
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 07 Sep 2015 New trial record
- 25 Aug 2015 Results published in the Journal of Antimicrobial Chemotherapy.